The prevalence of NAFLD was 23%. A high hs-CRP (>0.86 mg/L) was associated with NAFLD in multivariate analysis (OR 2.9; 95% CI 1.6–5.2); as was a high body mass index, abnormal aspartate aminotransferase, and insulin resistance. This evidence concerns the gene CRP and metabolic dysfunction-associated steatotic liver disease.